Nayiri Abnous
Optometrist · Pasadena, CANPI 1295367399
Payments from drug & device makers
Across 166 payments — averaging $23.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$810
- Bausch & Lomb Americas Inc.$592
- Oyster Point Pharma, Inc.$570
- Mallinckrodt Hospital Products Inc.$358
- Amgen$343
- Tarsus Pharmaceuticals, Inc.$298
- plus $909 from 7 others
What the payments were for
- Food & beverage$3,880100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 38 | $810 |
| Bausch & Lomb Americas Inc. | 29 | $592 |
| Oyster Point Pharma, Inc. | 28 | $570 |
| Mallinckrodt Hospital Products Inc. | 11 | $358 |
| Amgen | 22 | $343 |
| Tarsus Pharmaceuticals, Inc. | 11 | $298 |
| Dompe US, Inc. | 13 | $284 |
| Alcon | 5 | $213 |
| Aerie Pharmaceuticals, Inc. | 4 | $175 |
| Sight Sciences, Inc. | 1 | $143 |
| Harrow Eye, LLC | 2 | $40 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $39 |
| AbbVie | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OMNI(R) SURGICAL SYSTEM (US)$143
- Rocklatan$125
- Rhopressa$125
- TOTAL30$125
- Precision 1$125
- DAILIES TOTAL1$125
- MIEBO$124
- XIIDRA$124
How this compares
$3,880 in reported general payments places this provider in the 90th percentile of 6,778 optometrist providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 96 | $76,282 |
| XiidraLifitegrast | 85 | $74,934 |
| Cyclosporine | 43 | $25,089 |
| LumiganBimatoprost | 42 | $17,021 |
| CequaCyclosporine | 13 | $9,583 |
| RocklatanNetarsudil Mesylat/Latanoprost | 16 | $5,178 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 13 | $4,281 |
| Brimonidine Tartrate | 56 | $4,097 |
| Alphagan PBrimonidine Tartrate | 13 | $3,641 |
| Latanoprost | 471 | $3,145 |
| Prednisolone Acetate | 74 | $2,181 |
| Timolol Maleate | 117 | $2,125 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 83 | $1,473 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 16 | $650 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 18 | $488 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Alphagan P | $16 | $96,944151 claims |
| Bausch & Lomb Americas Inc.Xiidra | $592 | $74,93485 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $810 | $9,58313 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan | $175 | $5,17816 claims |
| AlconSimbrinza | $213 | $4,28113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,778 optometrist providers in California.
Other optometrist in Pasadena
- Meng LinBerkeley$6.9M
- Steve YoelinNewport Beach$6.1M
- Matthew GellerSpring Valley$3.5M
- David Kasanoffla Mesa$1M
- Colton HeinrichFullerton$987K
- Elsa PaoOakland$910K
- Keith WanSan Diego$887K
- Selena ChanSan Francisco$677K
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.